2022 annual financial data
BioRestorative Therapies 2022 Net income growth
Direct answer
Net income growth was 70.16%.
Operating income was -18,863,507 USD and net income was -13,222,296 USD.
Operating cash flow was -5,913,100 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 119,800 USD
- Operating income
- -18,863,507 USD
- Net income
- -13,222,296 USD
- Operating cash flow
- -5,913,100 USD